464280.KQ
Price:
$6090
Market Cap:
$32.21B
Established on November 11, 2002, TDS Pharm Co. Ltd. is headquartered in Seongnam-si, South Korea, and specializes in the creation and manufacturing of transdermal drug delivery solutions. Their offerings include items such as cataplasma, plasta, fucidin band, and various prescription pharmaceuticals.
Industry
Drug Manufacturers - General
IPO Date
2024-08-21
Stock Exchange
KOE
Ticker
464280.KQ
According to Tdspharm’s latest financial reports and current stock price. The company's current Current Ratio is 2.09. This represents a change of -31.91% compared to the average of 3.07 of the last 4 quarters.
The mean historical Current Ratio of Tdspharm over the last ten years is 2.23. The current 2.09 Current Ratio has changed 9.26% with respect to the historical average. Over the past ten years (40 quarters), 464280.KQ's Current Ratio was at its highest in in the September 2025 quarter at 3.82. The Current Ratio was at its lowest in in the March 2023 quarter at 0.
Average
2.23
Median
2.13
Minimum
1.34
Maximum
3.77
Discovering the peaks and valleys of Tdspharm Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 54.97%
Maximum Annual Current Ratio = 3.77
Minimum Annual Increase = -29.41%
Minimum Annual Current Ratio = 1.34
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 2.66 | -29.41% |
| 2024 | 3.77 | 54.97% |
| 2023 | 2.43 | 33.19% |
| 2022 | 1.83 | 33.26% |
| 2021 | 1.37 | 2.57% |
The current Current Ratio of Tdspharm (464280.KQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.95
5-year avg
2.41
10-year avg
2.23
Tdspharm’s Current Ratio is greater than Metacare Co., Ltd. (0.48), greater than BCWORLD PHARM. Co., Ltd. (0.53), less than Hass (3.18), greater than MYUNGMOON Pharm co.,Ltd (1.06), less than IVIM Technology (18.66), greater than Yuyu Pharma, Inc. (1.89), less than PharmGen Science, Inc. (3.33), greater than LAMEDITECH Co., Ltd. (1.41), greater than Yuyu Pharma, Inc. (1.89), less than ORIENT BIO Inc. (14.09),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.48 | $22.71B | |
| 0.53 | $30.87B | |
| 3.18 | $39.05B | |
| 1.06 | $40.62B | |
| 18.66 | $42.86B | |
| 1.89 | $52.93B | |
| 3.33 | $68.48B | |
| 1.41 | $25.53B | |
| 1.89 | $58.34B | |
| 14.09 | $54.49B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tdspharm using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tdspharm or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Tdspharm's Current Ratio?
How is the Current Ratio calculated for Tdspharm (464280.KQ)?
What is the highest Current Ratio for Tdspharm (464280.KQ)?
What is the 3-year average Current Ratio for Tdspharm (464280.KQ)?
What is the 5-year average Current Ratio for Tdspharm (464280.KQ)?
How does the current Current Ratio for Tdspharm (464280.KQ) compare to its historical average?